CLN5 Antibody
Product Specifications
Background
This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL) . Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.
NCBI Gene ID
1203
Swiss Prot
O75503
Host
Rabbit
Reactivity
Human, Mouse, Rat
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 96-407 of human CLN5 (NP_006484.1) .
Clonality
Polyclonal
Conjugation
Unconjugated
Type
Primary Antibodies
Field of Research
Neuroscience
Purification
Affinity purification
Positive Control
Mouse heart
Concentration
Batch dependent
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Store at -20˚ C. Avoid freeze / thaw cycles.
Calculated Molecular Weight
Observed: 41kDa
Fragment
IgG
Symbol
CLN5
Positive Control 2
Rat heart
NCBI Official Name
Ceroid-lipofuscinosis neuronal protein 5
NCBI Organism
Homo sapiens
Other Product Names
Ceroid-lipofuscinosis neuronal protein 5, Protein CLN5, CLN5
Tested Applications
WB, IHC
Physical Properties
Liquid
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036601-PE 200 µL
HIST2H2AC, ID (HIST2H2AC, H2AFQ, Histone H2A type 2-C, Histone H2A-GL101, Histone H2A/q) (PE) discontinued
Sign In for Pricing
View Details BNC940419-100 1x 100 µL
Transglutaminase II (TGM2/419), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details